{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:51:46Z","timestamp":1780501906743,"version":"3.54.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-68450-3","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T14:12:46Z","timestamp":1722262366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["In silico molecular screening of bioactive natural compounds of rosemary essential oil and extracts for pharmacological potentials against rhinoviruses"],"prefix":"10.1038","volume":"14","author":[{"given":"Dhananjay","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishu","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah Ud-Din","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A. M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis Ahmad","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Haris","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"68450_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1128\/cmr.00077-12","volume":"26","author":"SE Jacobs","year":"2013","unstructured":"Jacobs, S. E., Lamson, D. M., St George, K. & Walsh, T. J. Human rhinoviruses. Clin. Microbiol. Rev. 26, 135\u2013162. https:\/\/doi.org\/10.1128\/cmr.00077-12 (2013).","journal-title":"Clin. Microbiol. Rev."},{"key":"68450_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/v15040825","author":"S Ljubin-Sternak","year":"2023","unstructured":"Ljubin-Sternak, S. & Me\u0161trovi\u0107, T. Rhinovirus-a true respiratory threat or a common inconvenience of childhood?. Viruses https:\/\/doi.org\/10.3390\/v15040825 (2023).","journal-title":"Viruses"},{"key":"68450_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/apm.13202","volume":"130","author":"SR Warncke","year":"2022","unstructured":"Warncke, S. R. & Knudsen, C. R. Detection methods targeting the positive and negative-sense RNA transcripts from plus-stranded RNA viruses. Apmis 130, 284\u2013292. https:\/\/doi.org\/10.1111\/apm.13202 (2022).","journal-title":"Apmis"},{"key":"68450_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12879-022-07225-5","volume":"22","author":"R Jia","year":"2022","unstructured":"Jia, R. et al. Human rhinoviruses prevailed among children in the setting of wearing face masks in Shanghai. BMC Infect. Dis. 22, 253. https:\/\/doi.org\/10.1186\/s12879-022-07225-5 (2022).","journal-title":"BMC Infect. Dis."},{"key":"68450_CR5","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.jaci.2010.04.010","volume":"125","author":"AC Palmenberg","year":"2010","unstructured":"Palmenberg, A. C., Rathe, J. A. & Liggett, S. B. Analysis of the complete genome sequences of human rhinovirus. J. Allergy Clin. Immunol. 125, 1190\u20131199. https:\/\/doi.org\/10.1016\/j.jaci.2010.04.010 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"68450_CR6","doi-asserted-by":"publisher","first-page":"643219","DOI":"10.3389\/fped.2021.643219","volume":"9","author":"E Bizot","year":"2021","unstructured":"Bizot, E. et al. Rhinovirus: a narrative review on its genetic characteristics, pediatric clinical presentations, and pathogenesis. Front. Pediatr. 9, 643219. https:\/\/doi.org\/10.3389\/fped.2021.643219 (2021).","journal-title":"Front. Pediatr."},{"key":"68450_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00705-019-04520-6","volume":"165","author":"P Simmonds","year":"2020","unstructured":"Simmonds, P. et al. Recommendations for the nomenclature of enteroviruses and rhinoviruses. Arch. Virol. 165, 793\u2013797. https:\/\/doi.org\/10.1007\/s00705-019-04520-6 (2020).","journal-title":"Arch. Virol."},{"key":"68450_CR8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ajic.2022.12.005","volume":"51","author":"L Andrup","year":"2023","unstructured":"Andrup, L., Krogfelt, K. A., Hansen, K. S. & Madsen, A. M. Transmission route of rhinovirus - the causative agent for common cold. A systematic review. Am. J. Infect. Control 51, 938\u2013957. https:\/\/doi.org\/10.1016\/j.ajic.2022.12.005 (2023).","journal-title":"Am. J. Infect. Control"},{"key":"68450_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/v14112340","author":"JE Kreger","year":"2022","unstructured":"Kreger, J. E. & Hershenson, M. B. Effects of COVID-19 and social distancing on rhinovirus infections and asthma exacerbations. Viruses https:\/\/doi.org\/10.3390\/v14112340 (2022).","journal-title":"Viruses"},{"key":"68450_CR10","doi-asserted-by":"publisher","first-page":"27142","DOI":"10.1073\/pnas.1911083116","volume":"116","author":"S Nickbakhsh","year":"2019","unstructured":"Nickbakhsh, S. et al. Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc. Natl. Acad. Sci. U. S. A. 116, 27142\u201327150. https:\/\/doi.org\/10.1073\/pnas.1911083116 (2019).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"68450_CR11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1080\/22221751.2021.2021806","volume":"11","author":"M Essaidi-Laziosi","year":"2022","unstructured":"Essaidi-Laziosi, M. et al. Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract. Emerg. Microbes Infect. 11, 412\u2013423. https:\/\/doi.org\/10.1080\/22221751.2021.2021806 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"68450_CR12","doi-asserted-by":"publisher","first-page":"e2365","DOI":"10.1002\/rmv.2365","volume":"33","author":"H Krumbein","year":"2023","unstructured":"Krumbein, H. et al. Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis. Rev. Med. Virol. 33, e2365. https:\/\/doi.org\/10.1002\/rmv.2365 (2023).","journal-title":"Rev. Med. Virol."},{"key":"68450_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fddsv.2022.898035","author":"P Buchwald","year":"2022","unstructured":"Buchwald, P. Developing small-molecule inhibitors of protein-protein interactions involved in viral entry as potential antivirals for COVID-19. Front. Drug Discov. https:\/\/doi.org\/10.3389\/fddsv.2022.898035 (2022).","journal-title":"Front. Drug Discov."},{"key":"68450_CR14","doi-asserted-by":"publisher","first-page":"112298","DOI":"10.1016\/j.jep.2019.112298","volume":"248","author":"J Langeder","year":"2020","unstructured":"Langeder, J. et al. Natural products against acute respiratory infections: Strategies and lessons learned. J. Ethnopharmacol. 248, 112298. https:\/\/doi.org\/10.1016\/j.jep.2019.112298 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"68450_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/v14102235","author":"WJP van den Braak","year":"2022","unstructured":"van den Braak, W. J. P. et al. Construction of a vero cell line expressing human ICAM1 for the development of rhinovirus vaccines. Viruses https:\/\/doi.org\/10.3390\/v14102235 (2022).","journal-title":"Viruses"},{"key":"68450_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jfma.2017.04.009","volume":"116","author":"KKW To","year":"2017","unstructured":"To, K. K. W., Yip, C. C. Y. & Yuen, K. Y. Rhinovirus - From bench to bedside. J. Formos. Med. Assoc. 116, 496\u2013504. https:\/\/doi.org\/10.1016\/j.jfma.2017.04.009 (2017).","journal-title":"J. Formos. Med. Assoc."},{"key":"68450_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1128\/aac.49.2.619-626.2005","volume":"49","author":"SL Binford","year":"2005","unstructured":"Binford, S. L. et al. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. Antimicrob. Agents Chemother. 49, 619\u2013626. https:\/\/doi.org\/10.1128\/aac.49.2.619-626.2005 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"68450_CR18","doi-asserted-by":"publisher","first-page":"7487","DOI":"10.1038\/srep07487","volume":"4","author":"A Civra","year":"2014","unstructured":"Civra, A. et al. Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol. Sci. Rep. 4, 7487. https:\/\/doi.org\/10.1038\/srep07487 (2014).","journal-title":"Sci. Rep."},{"key":"68450_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.redox.2018.09.003","volume":"19","author":"A Civra","year":"2018","unstructured":"Civra, A. et al. 25-Hydroxycholesterol and 27-hydroxycholesterol inhibit human rotavirus infection by sequestering viral particles into late endosomes. Redox Biol. 19, 318\u2013330. https:\/\/doi.org\/10.1016\/j.redox.2018.09.003 (2018).","journal-title":"Redox Biol."},{"key":"68450_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mam.2016.04.003","volume":"49","author":"D Lembo","year":"2016","unstructured":"Lembo, D., Cagno, V., Civra, A. & Poli, G. Oxysterols: An emerging class of broad spectrum antiviral effectors. Mol. Aspects Med. 49, 23\u201330. https:\/\/doi.org\/10.1016\/j.mam.2016.04.003 (2016).","journal-title":"Mol. Aspects Med."},{"key":"68450_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41422-020-00398-1","volume":"30","author":"S Zu","year":"2020","unstructured":"Zu, S. et al. 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor. Cell Res. 30, 1043\u20131045. https:\/\/doi.org\/10.1038\/s41422-020-00398-1 (2020).","journal-title":"Cell Res."},{"key":"68450_CR22","doi-asserted-by":"publisher","first-page":"105368","DOI":"10.1016\/j.antiviral.2022.105368","volume":"204","author":"A Civra","year":"2022","unstructured":"Civra, A. et al. 27-Hydroxycholesterol inhibits rhinovirus replication in vitro and on human nasal and bronchial histocultures without selecting viral resistant variants. Antiviral Res. 204, 105368. https:\/\/doi.org\/10.1016\/j.antiviral.2022.105368 (2022).","journal-title":"Antiviral Res."},{"key":"68450_CR23","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1128\/aac.00946-12","volume":"56","author":"MJ Lamarche","year":"2012","unstructured":"Lamarche, M. J. et al. Anti-hepatitis C virus activity and toxicity of type III phosphatidylinositol-4-kinase beta inhibitors. Antimicrob. Agents Chemother. 56, 5149\u20135156. https:\/\/doi.org\/10.1128\/aac.00946-12 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"68450_CR24","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1021\/acs.jmedchem.5b01311","volume":"59","author":"FU Rutaganira","year":"2016","unstructured":"Rutaganira, F. U. et al. Design and structural characterization of potent and selective inhibitors of phosphatidylinositol 4 kinase III\u03b2. J. Med. Chem. 59, 1830\u20131839. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01311 (2016).","journal-title":"J. Med. Chem."},{"key":"68450_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","volume":"110","author":"JF Rossignol","year":"2014","unstructured":"Rossignol, J. F. Nitazoxanide: A first-in-class broad-spectrum antiviral agent. Antiviral Res. 110, 94\u2013103. https:\/\/doi.org\/10.1016\/j.antiviral.2014.07.014 (2014).","journal-title":"Antiviral Res."},{"key":"68450_CR26","unstructured":"Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus\/Rhinovirus Infection. Trial ID: NCT03605862. 2023, Status: Undder phase III. Available online: https:\/\/clinicaltrials.gov\/study\/NCT03605862(accessed on 17 November 2023)."},{"key":"68450_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov, A. G., Zotchev, S. B., Dirsch, V. M. & Supuran, C. T. Natural products in drug discovery: Advances and opportunities. Nat. Rev. Drug Discov. 20, 200\u2013216. https:\/\/doi.org\/10.1038\/s41573-020-00114-z (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"68450_CR28","doi-asserted-by":"publisher","first-page":"e202300277","DOI":"10.1002\/slct.202300277","volume":"8","author":"AR Issahaku","year":"2023","unstructured":"Issahaku, A. R. et al. Discovery of potential KRAS-SOS1 inhibitors from South African natural compounds: An in silico approach. Chem. Sel. 8, e202300277. https:\/\/doi.org\/10.1002\/slct.202300277 (2023).","journal-title":"Chem. Sel."},{"key":"68450_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1185236","author":"R Baru Venkata","year":"2023","unstructured":"Baru Venkata, R. et al. Utilizing Andrographis paniculata leaves and roots by effective usage of the bioactive andrographolide and its nanodelivery: Investigation of antikindling and antioxidant activities through in silico and in vivo studies. Front. Nutr. https:\/\/doi.org\/10.3389\/fnut.2023.1185236 (2023).","journal-title":"Front. Nutr."},{"key":"68450_CR30","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.2174\/1871530321666210520102042","volume":"21","author":"A Ahmad","year":"2021","unstructured":"Ahmad, A., Tiwari, R. K. & Ansari, I. A. Revisiting the antiviral efficacy of terpenoids: Plausible adjunct therapeutics for novel SARS-CoV-2?. Endocr. Metab. Immune Disord. Drug Targets 21, 2119\u20132130. https:\/\/doi.org\/10.2174\/1871530321666210520102042 (2021).","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"68450_CR31","first-page":"e80651","volume":"3","author":"R Ahmed","year":"2010","unstructured":"Ahmed, R. & Abdella, E. Modulatory effects of rosemary leaves aqueous extract on doxorubicin-induced histological lesions, apoptosis and oxidative stress in mice. Int. J. Cancer Manag. 3, e80651 (2010).","journal-title":"Int. J. Cancer Manag."},{"key":"68450_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12929-019-0499-8","volume":"26","author":"JR de Oliveira","year":"2019","unstructured":"de Oliveira, J. R., Camargo, S. E. A. & de Oliveira, L. D. Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent. J. Biomed. Sci. 26, 5. https:\/\/doi.org\/10.1186\/s12929-019-0499-8 (2019).","journal-title":"J. Biomed. Sci."},{"key":"68450_CR33","first-page":"187","volume":"29","author":"H Rasoolijazi","year":"2015","unstructured":"Rasoolijazi, H. et al. The effect of rosemary extract on spatial memory, learning and antioxidant enzymes activities in the hippocampus of middle-aged rats. Med. J. Islam Repub. Iran 29, 187 (2015).","journal-title":"Med. J. Islam Repub. Iran"},{"key":"68450_CR34","first-page":"156","volume":"7","author":"D Singh","year":"2023","unstructured":"Singh, D., Mittal, N. & Siddiqui, M. H. A review on pharmacological potentials of phenolic diterpenes carnosic acid and carnosol obtained from Rosmarinus officinalis L. and modern extraction methods implicated in their recovery. Trends Phytochem. Res. 7, 156\u2013169 (2023).","journal-title":"Trends Phytochem. Res."},{"key":"68450_CR35","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20200992","author":"WA Al-Megrin","year":"2020","unstructured":"Al-Megrin, W. A. et al. Potential antiviral agents of Rosmarinus officinalis extract against herpes viruses 1 and 2. Biosci. Rep. https:\/\/doi.org\/10.1042\/bsr20200992 (2020)."},{"key":"68450_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3233\/MNM-210013","volume":"14","author":"A Shiravi","year":"2021","unstructured":"Shiravi, A. et al. Rosemary and its protective potencies against COVID-19 and other cytokine storm associated infections: A molecular review. Mediterr. J. Nutr. Metab. 14, 401\u2013416. https:\/\/doi.org\/10.3233\/MNM-210013 (2021).","journal-title":"Mediterr. J. Nutr. Metab."},{"key":"68450_CR37","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.jiph.2021.09.001","volume":"14","author":"AS Alshrari","year":"2021","unstructured":"Alshrari, A. S. et al. Bioinformatics analysis of rhinovirus capsid proteins VP1-4 sequences for cross-serotype vaccine development. J. Infect. Public Health 14, 1603\u20131611. https:\/\/doi.org\/10.1016\/j.jiph.2021.09.001 (2021).","journal-title":"J. Infect. Public Health"},{"key":"68450_CR38","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/s0969-2126(97)00199-8","volume":"5","author":"AT Hadfield","year":"1997","unstructured":"Hadfield, A. T. et al. The refined structure of human rhinovirus 16 at 2.15 A resolution: Implications for the viral life cycle. Structure 5, 427\u2013441. https:\/\/doi.org\/10.1016\/s0969-2126(97)00199-8 (1997).","journal-title":"Structure"},{"key":"68450_CR39","doi-asserted-by":"publisher","unstructured":"UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res 51, D523-d531, https:\/\/doi.org\/10.1093\/nar\/gkac1052 (2023).","DOI":"10.1093\/nar\/gkac1052"},{"key":"68450_CR40","doi-asserted-by":"crossref","unstructured":"Gasteiger, E. et al. in The Proteomics Protocols Handbook (ed John M. Walker) 571\u2013607 (Humana Press, 2005).","DOI":"10.1385\/1-59259-890-0:571"},{"key":"68450_CR41","doi-asserted-by":"publisher","first-page":"D418","DOI":"10.1093\/nar\/gkac993","volume":"51","author":"T Paysan-Lafosse","year":"2023","unstructured":"Paysan-Lafosse, T. et al. InterPro in 2022. Nucleic Acids Res. 51, D418\u2013D427 (2023).","journal-title":"Nucleic Acids Res."},{"key":"68450_CR42","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gky473","volume":"46","author":"W Tian","year":"2018","unstructured":"Tian, W., Chen, C., Lei, X., Zhao, J. & Liang, J. CASTp 3.0: Computed atlas of surface topography of proteins. Nucleic Acids Res 46, W363-w367. https:\/\/doi.org\/10.1093\/nar\/gky473 (2018).","journal-title":"Nucleic Acids Res"},{"key":"68450_CR43","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2022","unstructured":"Kim, S. et al. PubChem 2023 update. Nucleic Acids Res 51, D1373\u2013D1380. https:\/\/doi.org\/10.1093\/nar\/gkac956 (2022).","journal-title":"Nucleic Acids Res"},{"key":"68450_CR44","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires, D. E. V., Blundell, T. L. & Ascher, D. B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58, 4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104 (2015).","journal-title":"J. Med. Chem."},{"key":"68450_CR45","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41401-019-0228-6","volume":"41","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. CB-Dock: A web server for cavity detection-guided protein\u2013ligand blind docking. Acta Pharmacol. Sin. 41, 138\u2013144. https:\/\/doi.org\/10.1038\/s41401-019-0228-6 (2020).","journal-title":"Acta Pharmacol. Sin."},{"key":"68450_CR46","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778\u20132786. https:\/\/doi.org\/10.1021\/ci200227u (2011).","journal-title":"J. Chem. Inf. Model."},{"key":"68450_CR47","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1093\/bioinformatics\/btu104","volume":"30","author":"Y Cao","year":"2014","unstructured":"Cao, Y. & Li, L. Improved protein-ligand binding affinity prediction by using a curvature-dependent surface-area model. Bioinformatics 30, 1674\u20131680. https:\/\/doi.org\/10.1093\/bioinformatics\/btu104 (2014).","journal-title":"Bioinformatics"},{"key":"68450_CR48","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2147\/jep.S255211","volume":"13","author":"JA Coultas","year":"2021","unstructured":"Coultas, J. A., Cafferkey, J., Mallia, P. & Johnston, S. L. Experimental antiviral therapeutic studies for human rhinovirus infections. J. Exp. Pharmacol. 13, 645\u2013659. https:\/\/doi.org\/10.2147\/jep.S255211 (2021).","journal-title":"J. Exp. Pharmacol."},{"key":"68450_CR49","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1086\/375069","volume":"36","author":"FG Hayden","year":"2003","unstructured":"Hayden, F. G. et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: Results of 2 double-blind, randomized, placebo-controlled trials. Clin. Infect. Dis. 36, 1523\u20131532. https:\/\/doi.org\/10.1086\/375069 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"68450_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/v11060521","author":"S Vandini","year":"2019","unstructured":"Vandini, S., Biagi, C., Fischer, M. & Lanari, M. Impact of rhinovirus infections in children. Viruses https:\/\/doi.org\/10.3390\/v11060521 (2019).","journal-title":"Viruses"},{"key":"68450_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/v14081829","author":"F Neugebauer","year":"2022","unstructured":"Neugebauer, F., Bergs, S., Liebert, U. G. & H\u00f6nemann, M. Human rhinoviruses in pediatric patients in a tertiary care hospital in germany: molecular epidemiology and clinical significance. Viruses https:\/\/doi.org\/10.3390\/v14081829 (2022).","journal-title":"Viruses"},{"key":"68450_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1132538","author":"B Kasabe","year":"2023","unstructured":"Kasabe, B. et al. Drug repurposing approach against chikungunya virus: an in vitro and in silico study. Front. Cell. Infect. Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2023.1132538 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"68450_CR53","doi-asserted-by":"publisher","first-page":"101127","DOI":"10.1016\/j.xcrm.2023.101127","volume":"4","author":"R Narayan","year":"2023","unstructured":"Narayan, R. et al. Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo. Cell Rep. Med. 4, 101127. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101127 (2023).","journal-title":"Cell Rep. Med."},{"key":"68450_CR54","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00203-023-03441-y","volume":"205","author":"M Paschoalino","year":"2023","unstructured":"Paschoalino, M. et al. An update on the development of antiviral against Mayaro virus: From molecules to potential viral targets. Arch. Microbiol. 205, 106. https:\/\/doi.org\/10.1007\/s00203-023-03441-y (2023).","journal-title":"Arch. Microbiol."},{"key":"68450_CR55","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12985-023-01968-6","volume":"20","author":"W Wu","year":"2023","unstructured":"Wu, W., Cheng, Y., Zhou, H., Sun, C. & Zhang, S. The SARS-CoV-2 nucleocapsid protein: Its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics. Virol. J. 20, 6. https:\/\/doi.org\/10.1186\/s12985-023-01968-6 (2023).","journal-title":"Virol. J."},{"key":"68450_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00894-023-05569-6","volume":"29","author":"U Patel","year":"2023","unstructured":"Patel, U., Desai, K., Dabhi, R. C., Maru, J. J. & Shrivastav, P. S. Bioprospecting phytochemicals of Rosmarinus officinalis L. for targeting SARS-CoV-2 main protease (M(pro)): A computational study. J. Mol. Model. 29, 161. https:\/\/doi.org\/10.1007\/s00894-023-05569-6 (2023).","journal-title":"J. Mol. Model."},{"key":"68450_CR57","unstructured":"Peng, H. et al. In vitro inhibition of carnosic acid against influenza A virus infections. Acta Pharm. Sin., 12, 360\u2013370 (2023)."},{"key":"68450_CR58","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2381680\/v1","author":"D Poy","year":"2023","unstructured":"Poy, D. & Tohidfar, M. An in silico investigation and introduction of some secondary metabolites of medicinal plants with antiviral activity and effective vitamins for the treatment of MPox. Res. Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-2381680\/v1 (2023).","journal-title":"Res. Sq."},{"key":"68450_CR59","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12985-023-02160-6","volume":"20","author":"SS Alkafaas","year":"2023","unstructured":"Alkafaas, S. S. et al. A study on the effect of natural products against the transmission of B.1.1.529 Omicron. Virol. J. 20, 191. https:\/\/doi.org\/10.1186\/s12985-023-02160-6 (2023).","journal-title":"Virol. J."},{"key":"68450_CR60","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.3390\/molecules27196374","volume":"27","author":"P Kashyap","year":"2022","unstructured":"Kashyap, P. et al. In silico evaluation of natural flavonoids as a potential inhibitor of coronavirus disease. Molecules 27, 6374 (2022).","journal-title":"Molecules"},{"key":"68450_CR61","doi-asserted-by":"publisher","first-page":"e31318","DOI":"10.1097\/md.0000000000031318","volume":"102","author":"S Khan","year":"2023","unstructured":"Khan, S. et al. In-silico studies of inhibitory compounds against protease enzymes of SARS-CoV-2. Medicine (Baltimore) 102, e31318. https:\/\/doi.org\/10.1097\/md.0000000000031318 (2023).","journal-title":"Medicine (Baltimore)"},{"key":"68450_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jtcme.2023.07.004","volume":"14","author":"SK Mandal","year":"2024","unstructured":"Mandal, S. K. et al. In silico anti-viral assessment of phytoconstituents in a traditional (Siddha Medicine) polyherbal formulation - Targeting Mpro and pan-coronavirus post-fusion Spike protein. J. Tradit. Complement. Med. 14, 55\u201369. https:\/\/doi.org\/10.1016\/j.jtcme.2023.07.004 (2024).","journal-title":"J. Tradit. Complement. Med."},{"key":"68450_CR63","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1080\/07391102.2022.2046640","volume":"41","author":"HSH Mohammed Ali","year":"2023","unstructured":"Mohammed Ali, H. S. H. et al. In silico screening of the effectiveness of natural compounds from algae as SARS-CoV-2 inhibitors: molecular docking, ADMT profile and molecular dynamic studies. J. Biomol. Struct. Dyn. 41, 3129\u20133144. https:\/\/doi.org\/10.1080\/07391102.2022.2046640 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"68450_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24055003","author":"RJ Obaid","year":"2023","unstructured":"Obaid, R. J. et al. In silico screening and molecular dynamics simulation studies in the identification of natural compound inhibitors targeting the human norovirus RdRp protein to fight gastroenteritis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24055003 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"68450_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.599079","author":"DM Teli","year":"2021","unstructured":"Teli, D. M., Shah, M. B. & Chhabria, M. T. In silico screening of natural compounds as potential inhibitors of SARS-CoV-2 main protease and spike RBD: Targets for COVID-19. Front. Mol. Biosci. https:\/\/doi.org\/10.3389\/fmolb.2020.599079 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"68450_CR66","doi-asserted-by":"publisher","first-page":"17796","DOI":"10.1038\/s41598-022-22668-1","volume":"12","author":"AR Issahaku","year":"2022","unstructured":"Issahaku, A. R. et al. Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy. Sci. Rep. 12, 17796. https:\/\/doi.org\/10.1038\/s41598-022-22668-1 (2022).","journal-title":"Sci. Rep."},{"key":"68450_CR67","doi-asserted-by":"publisher","first-page":"8656","DOI":"10.1038\/s41598-023-35161-0","volume":"13","author":"M Rudrapal","year":"2023","unstructured":"Rudrapal, M. et al. Dual synergistic inhibition of COX and LOX by potential chemicals from Indian daily spices investigated through detailed computational studies. Sci. Rep. 13, 8656. https:\/\/doi.org\/10.1038\/s41598-023-35161-0 (2023).","journal-title":"Sci. Rep."},{"key":"68450_CR68","doi-asserted-by":"publisher","first-page":"e202103908","DOI":"10.1002\/slct.202103908","volume":"7","author":"JA Ezugwu","year":"2022","unstructured":"Ezugwu, J. A. et al. Design, synthesis, molecular docking, molecular dynamics and in vivo antimalarial activity of new dipeptide-sulfonamides. Chem. Sel. 7, e202103908. https:\/\/doi.org\/10.1002\/slct.202103908 (2022).","journal-title":"Chem. Sel."},{"key":"68450_CR69","doi-asserted-by":"publisher","first-page":"130862","DOI":"10.1016\/j.molstruc.2021.130862","volume":"1243","author":"IMM Othman","year":"2021","unstructured":"Othman, I. M. M. et al. Toward a treatment of antibacterial and antifungal infections: Design, synthesis and in vitro activity of novel arylhydrazothiazolylsulfonamides analogues and their insight of DFT, docking and molecular dynamic simulations. J. Mol. Struct. 1243, 130862. https:\/\/doi.org\/10.1016\/j.molstruc.2021.130862 (2021).","journal-title":"J. Mol. Struct."},{"key":"68450_CR70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11030-023-10783-8","volume":"28","author":"M Rudrapal","year":"2024","unstructured":"Rudrapal, M., Kirboga, K. K., Abdalla, M. & Maji, S. Explainable artificial intelligence-assisted virtual screening and bioinformatics approaches for effective bioactivity prediction of phenolic cyclooxygenase-2 (COX-2) inhibitors using PubChem molecular fingerprints. Mol. Div. 28, 1\u201320 (2024).","journal-title":"Mol. Div."},{"key":"68450_CR71","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s13659-022-00366-9","volume":"13","author":"S Faisal","year":"2023","unstructured":"Faisal, S., Badshah, S. L., Kubra, B., Emwas, A. H. & Jaremko, M. Alkaloids as potential antivirals. A comprehensive review. Nat. Prod. Bioprospect. 13, 4. https:\/\/doi.org\/10.1007\/s13659-022-00366-9 (2023).","journal-title":"Nat. Prod. Bioprospect."},{"key":"68450_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124424","author":"R Makkar","year":"2020","unstructured":"Makkar, R. et al. Nutraceuticals in neurological disorders. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21124424 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"68450_CR73","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/1570159x18666200207120949","volume":"18","author":"S Singh","year":"2020","unstructured":"Singh, S. & Singh, T. G. Role of nuclear factor kappa B (NF-\u03baB) signalling in neurodegenerative diseases: An mechanistic approach. Curr. Neuropharmacol. 18, 918\u2013935. https:\/\/doi.org\/10.2174\/1570159x18666200207120949 (2020).","journal-title":"Curr. Neuropharmacol."},{"key":"68450_CR74","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12985-022-01799-x","volume":"19","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. A severe case of human rhinovirus A45 with central nervous system involvement and viral sepsis. Virol. J. 19, 72. https:\/\/doi.org\/10.1186\/s12985-022-01799-x (2022).","journal-title":"Virol. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68450-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68450-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68450-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T14:16:12Z","timestamp":1722262572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68450-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["68450"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-68450-3","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"19 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17426"}}